Economy

Stocks have literally never been this expensive

Stocks have literally never been this expensive

Global stock exchanges are currently at levels of valuation that are unusually high. This scenario has investors, analysts, and regulatory authorities intensely scrutinizing if such pricing is maintainable. In various industries, shares in comparison to profits, net asset value, and other essential indicators have increased significantly, sparking discussions about a possible overvaluation and the dangers of a market adjustment.Analysts often point to the price-to-earnings (P/E) ratio as a key indicator of stock valuation. Current data shows that the average P/E ratio in major indices has reached levels not seen in decades. While some argue that low interest rates and easy…
Read More
Fed losing independence would pose a serious danger, says Lagarde

Fed losing independence would pose a serious danger, warns Lagarde

La autonomía de los bancos centrales ha sido durante mucho tiempo un pilar fundamental para la estabilidad económica, actuando como un resguardo contra la interferencia política en la política monetaria. Recientemente, la presidenta del Banco Central Europeo, Christine Lagarde, enfatizó este principio con una advertencia clara: cualquier debilitamiento de la autonomía de la Reserva Federal generaría riesgos importantes para los mercados financieros, el crecimiento económico y la confianza pública en las instituciones. Su declaración refleja una creciente preocupación entre los economistas de que la independencia de los bancos centrales, anteriormente considerada un hecho, enfrenta presiones sin precedentes en un escenario…
Read More
Trump backs down from 250% EU pharma tariff in deal

Trump scraps 250% EU pharma tariff in settlement

The escalating trade tensions between Washington and Brussels took a significant turn as former U.S. President Donald Trump agreed to withdraw plans for imposing an extraordinarily high tariff—reportedly 250 percent—on pharmaceutical imports from the European Union. This decision, which came as part of a broader trade arrangement, marks a critical moment in the long-standing negotiations between the two economic powerhouses and offers a temporary reprieve for industries on both sides of the Atlantic.The dispute traces back to a period of intensifying trade frictions, during which Washington sought to correct what it viewed as persistent imbalances and unfair practices in sectors…
Read More
Beijing opposes 'bully' US for 50% tariffs on India

Beijing opposes ‘bully’ US for 50% tariffs on India

El panorama del comercio mundial ha entrado en otra fase turbulenta, mientras que Beijing ha criticado con dureza la reciente decisión de Washington de imponer altos aranceles a los productos que provienen de India. Esta medida, que establece un arancel del 50 por ciento sobre una variedad de exportaciones indias hacia los Estados Unidos, ha generado un amplio debate sobre el proteccionismo, la estrategia económica y el futuro de las relaciones comerciales internacionales.China’s condemnation of the policy came swiftly, framing the decision as an example of what it terms “bullying tactics” within the global economic system. According to Chinese officials,…
Read More
Trump backs down from 250% EU pharma tariff in deal

Trump steps away from 250% EU pharma tariff in deal

The possibility of a trade war between the United States and the European Union has been averted after former U.S. President Donald Trump agreed to drop plans for a massive tariff on European pharmaceutical imports. Initially, the Trump administration had signaled the introduction of a 250% tariff on drugs coming from Europe, a move that alarmed both industry leaders and healthcare organizations worldwide. However, following weeks of tense negotiations, both sides have announced a deal aimed at maintaining stability in the global pharmaceutical market.The proposed tariff emerged as part of a broader strategy designed to protect American manufacturing and reduce…
Read More